Diabetes Drug Reduces Acute GVHD After Stem Cell Transplant ...Middle East

Medscape - News
Adding the diabetes drug sitaliptin to immunosuppression therapies for patients undergoing stem cell transplant reduced the risk of developing acute graft-vs-host disease (GVHD). Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Diabetes Drug Reduces Acute GVHD After Stem Cell Transplant )

Apple Storegoogle play

Also on site :